& LEAD-6 Study Group
Additionally, the risk of pancreatic cancer was 59% lower, and the risk of hepatocellular carcinoma was 53% lower
doi: 10.1097/JIM.0000000000000129 156 KingMRAndersonNJDeciuMGuernseyLSCundiffMHajizadehSet al
In addition to its effectiveness for weight loss, semaglutide may improve metabolic health, including better blood sugar control and lower cardiovascular risk factorsespecially important for our patients with overweight or obesity who also have type 2 diabetes
One of the innovative treatments we offer is the use of GLP-1 medications, such as Ozempic (semaglutide), which have recently gained widespread attention for their effectiveness in weight management and metabolic health
No systematic data exist regarding developmental safety, effects on linear growth and pubertal progression, or long-term cardiometabolic consequences in this population